Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

BFRA

Biofrontera (BFRA)

Biofrontera AG
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BFRA
일자시간출처헤드라인심볼기업
2022/03/1419:06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BFRABiofrontera AG
2022/03/1020:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
2022/03/1006:28Edgar (US Regulatory)Notice of Termination of a Foreign Private Issuer's Registration of a Class of Securities Under Section 12(b) (15f-12b)NASDAQ:BFRABiofrontera AG
2022/03/1004:36Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:BFRABiofrontera AG
2022/03/1004:29Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:BFRABiofrontera AG
2022/02/2606:03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BFRABiofrontera AG
2022/02/2506:06Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:BFRABiofrontera AG
2022/02/2504:14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
2022/02/2300:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
2022/02/1504:05GlobeNewswire Inc.Biofrontera AG decides to delist ADS from Nasdaq to reduce complexity and costsNASDAQ:BFRABiofrontera AG
2022/02/0200:00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
2022/01/1323:26Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
2021/12/1504:24Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
2021/12/1400:23Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
2021/12/0822:44Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
2021/12/0300:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
2021/12/0221:37Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
2021/12/0220:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
2021/11/3006:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BFRABiofrontera AG
2021/11/3003:13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
2021/11/3000:24Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
2021/11/2500:13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
2021/11/2001:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
2021/11/1922:45GlobeNewswire Inc.Biofrontera AG announces mediation resultsNASDAQ:BFRABiofrontera AG
2021/11/1820:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
2021/11/1807:00GlobeNewswire Inc.Biofrontera reports financial results for the third quarter and nine months ended September 30, 2021NASDAQ:BFRABiofrontera AG
2021/11/1701:41Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
2021/11/1623:01GlobeNewswire Inc.Biofrontera AG announces initiation of clinical studiesNASDAQ:BFRABiofrontera AG
2021/11/1023:29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
2021/11/1000:30Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
 검색 관련기사 보기:NASDAQ:BFRA